A chronobiological policy to decrease the burden of hypertension and obesity in low- and middle-income population

Biological Rhythm Research

Volumn 43, Issue 1, 2012, Pages 81-102

  Levandovski, Rosa ^a   Harb, Ana ^a,b   Bernardi, Fabiana ^a   Allebrandt, Karla V ^c   Hidalgo, Maria Paz Loayza ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

antihypertensive drugs; arterial hypertension; circadian rhythms; obesity and sleep quality

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ISRADIPINE; NIFEDIPINE; PERINDOPRIL; SPIRONOLACTONE; VALSARTAN;

CARDIOVASCULAR DISEASE; CHRONOLOGY; CIRCADIAN RHYTHM; DIABETES; DRUG; EPIDEMIOLOGY; HEALTH POLICY; HEALTH RISK; HOMEOSTASIS; HORMONE; HYPERTENSION; LOW INCOME POPULATION; MUTATION; NERVOUS SYSTEM; OBESITY; PUBLIC HEALTH; RISK FACTOR; SLEEP;

BLOOD PRESSURE REGULATION; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EVENING DOSAGE; HUMAN; HYPERTENSION; LOWEST INCOME GROUP; MORNING DOSAGE; NONHUMAN; OBESITY; RISK FACTOR; SOCIOECONOMICS; SYSTEMATIC REVIEW;

BRAZIL;

EID: 84857354556     PISSN: 09291016     EISSN: 17444179     Source Type: Journal    
DOI: 10.1080/09291016.2011.638162     Document Type: Conference Paper

References (50)

1. Antunes LC, Levandovski R, Dantas G, Caumo W, Hidalgo MP. 2010. Obesity and shift work: chronobiological aspects. Nutr Res Rev. 23(1):155-168.
2. Bernabe-Ortiz A, Gilman RH, Smeeth L, Miranda JJ. 2010. Migration surrogates and their association with obesity among within-country migrants. Obesity. (Silver Spring) 18(11): 2199-2203.
3. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. 2005. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 90(8):4510-4515.
4. Bonow R, Mann D, Zipes D, Libby P. 2011. Braunwald's heart disease: a textbook of cardiovascular medicine. Vol. 9. p. 2048.
5. Cornelissen G, Chen CH, Halberg F. 2006. Ambulatory blood-pressure monitoring. N Engl J Med. 355(8):850-851.
6. Cornelissen G, Halberg F, Bakken EE, Wang Z, Tarquini R, Perfetto F, Laffi G, Maggioni C, Kumagai Y, Homolka P, et al. 2007. Chronobiology of high blood pressure. Scr Med. (Brno) 80(4):157-166.
7. Crispim CA, Waterhouse J, Damaso AR, Zimberg IZ, Padilha HG, Oyama LM, Tufik S, de Mello MT. Forthcoming 2011. Hormonal appetite control is altered by shift work: a preliminary study. Metabolism.
8. Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517-549.
9. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. 2007. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 30(12):1667-1673.
10. Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F. 2008. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 22(9):627-633.
11. Halberg F. 1976. Chronobiology in 1975. Chronobiologia. 3(1):1-11.
12. Harb ABC, Caumo W, Raupp P, Hidalgo MPL. 2010. Sindrome do Comer Noturno: aspectos conceituais, epidemiologicos, diagnosticos e terapeuticos. Revista de Nutriçã o. 23:127-136.
13. Hermida RC, Ayala DE, Calvo C. 2007. Optimal timing for antihypertensive dosing: focus on valsartan. Ther Clin Risk Manag. 3(1):119-131.
14. IBGE (Instituto Brasileiro de Geografia e Estatística). 2010. Pesquisa de Orçamentos Familiares (POF) 2008-2009. Antropometria e estado nutricional do crianç as, adolescents e adultos no Brasil. Available at 5http://www.ibge.gov.br/home/presidencia/ noticias/noticia-visualiza.php?id- noticia1699&id-pagina14 Accessed October 2011.
15. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. 2000. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 278(5):E941-E948.
16. Kishi T, Elmquist JK. 2005. Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry. 10(2):132-146.
17. Kohsaka A, Bass J. 2007. A sense of time: how molecular clocks organize metabolism. Trends Endocrinol Metab. 18(1):4-11.
18. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S. 2007. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 115(9):1067-1074.
19. Lemmer B. 2006. The importance of circadian rhythms on drug response in hypertension and coronary heart disease - from mice and man. Pharmacol Ther. 111(3):629-651.
20. Lemmer B, Nold G. 1991. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol. 32(5):627-629.
21. Lemmer B, Schiffer S, Witte K, Gorbey S. 2005. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosinehydroxylase and reuptake1-transporter. Chronobiol Int. 22(3):473-488.
22. Lemmer B, Witte K, Enzminger H, Schiffer S, Hauptfleisch S. 2003. Transgenic TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of the brain, the heart, and the kidneys. Chronobiol Int. 20(4):711-738.
23. Maggioni C, Cornelissen G, Otsuka K, Halberg F, Consonni D, Nicolini U. 2005. Circadian rhythm of maternal blood pressure and fetal growth. Biomed Pharmacother. 59 Suppl 1:S86-S91.
24. Mittal BV, Singh AK. 2010. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 55(3):590-598.
25. Monteiro CA, Conde WL, Popkin BM. 2002. Is obesity replacing or adding to undernutrition? Evidence from different social classes in Brazil. Public Health Nutr. 5(1A):105-112.
26. Monteiro CA, Moura EC, Conde WL, Popkin BM. 2004. Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ. 82:940-946.
27. Nonaka H, Emoto N, Ikeda K, Fukuya H, Rohman MS, Raharjo SB, Yagita K, Okamura H, Yokoyama M. 2001. Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation. 104(15):1746-1748.
28. Obregon AM, Amador P, Valladares M, Weisstaub G, Burrows R, Santos JL. 2010. Melanocortin-3 receptor gene variants: association with childhood obesity and eating behavior in Chilean families. Nutrition. 26(7-8):760-765.
29. Ordunez P, Silva LC, Rodriguez MP, Robles S. 2001. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Salud Publica. 10(4):226-231.
30. Page C, Curtis M, Sutter M, Walker M, Hoffman B. 2004. Farmacologia integrada. 2ed. Manole. p. 670.
31. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. 1995. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 8(7):719-726.
32. Rahmouni K. 2010. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev. 6(2):104-209.
33. Rod NH, Vahtera J, Westerlund H, Kivimaki M, Zins M, Goldberg M, Lange T. 2011. Sleep disturbances and cause-specific mortality: results from the GAZEL cohort study. Am J Epidemiol. 173(3):300-309.
34. Rubinstein A, Colantonio L, Bardach A, Caporale J, Marti SG, Kopitowski K, Alcaraz A, Gibbons L, Augustovski F, Pichon-Riviere A. 2010. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health. 10:627.
35. Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA. 2004. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2(11):e377.
36. Salgado-Delgado R, Angeles-Castellanos M, Saderi N, Buijs RM, Escobar C. 2010. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology. 151(3):1019-1029.
37. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, Touboul PJ, Boissonnet CP, Escobedo J, Pellegrini F, et al. 2008. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 121(1):58-65.
38. Shimba S, Ishii N, Ohta Y, Ohno T, Watabe Y, Hayashi M, Wada T, Aoyagi T, Tezuka M. 2005. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci USA. 102(34):12071-12076.
39. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, et al. 2005. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 308(5724):1043-1045.
40. Uzu T, Kimura G. 1999. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 100(15):1635-1638.
41. Valladares M, Dominguez-Vasquez P, Obregon AM, Weisstaub G, Burrows R, Maiz A, Santos JL. 2010. Melanocortin-4 receptor gene variants in Chilean families: association with childhood obesity and eating behavior. Nutr Neurosci. 13(2):71-78.
42. Wajchenberg BL. 2000. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 21(6):697-738.
43. Waterhouse J, Bailey L, Tomlinson F, Edwards B, Atkinson G, Reilly T. 2005. Food intake in healthy young adults: effects of time pressure and social factors. Chronobiol Int. 22(6):1069-1092.
44. WHO (World Health Organization). 2009. Global health risks: mortality and burden of disease attributable to selected major risks. Available at 5http://www.who.int/healthinfo/ global-burden-disease/GlobalHealthRisks-report- full.pdf4 Accessed October 2011. http://www.seer.cancer.gov.
45. WHO (World Health Organization). 2011. Obesity and overweight Fact sheet n 311. Available at 5http://www.who.int/mediacentre/factsheets/fs311/en/4 Accessed October 2011.
46. Williams B. 2010. The Year in Hypertension. J Am Coll Cardiol. 55(1):65-73.
47. Wyss JM, Carlson SH. 2001. The role of the nervous system in hypertension. Curr Hypertens Rep. 3(3):255-262.
48. Yang X, Downes M, Yu RT, Bookout AL, He W, Straume M, Mangelsdorf DJ, Evans RM. 2006. Nuclear receptor expression links the circadian clock to metabolism. Cell. 126(4): 801-810.
49. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. 2005. Race-ethnicityspecific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr. 81(2):409-415.
50. Zvonic S, Ptitsyn AA, Conrad SA, Scott LK, Floyd ZE, Kilroy G, Wu X, Goh BC, Mynatt RL, Gimble JM. 2006. Characterization of peripheral circadian clocks in adipose tissues. Diabetes. 55(4):962-970.